IRON – disc medicine, inc. (US:NASDAQ)
Stock Stats
News
Disc Medicine, Inc. (NASDAQ: IRON) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $85.00 price target on the stock.
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
Disc Medicine, Inc. (NASDAQ: IRON) had its price target raised by analysts at Raymond James from $40.00 to $43.00. They now have an "outperform" rating on the stock.
Form 10-Q Disc Medicine, Inc. For: Mar 31
Form 8-K Disc Medicine, Inc. For: May 09
Form 4 Disc Medicine, Inc. For: May 01 Filed by: White William Richard
Form DEF 14A Disc Medicine, Inc. For: Jun 12
Form ARS Disc Medicine, Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.